Dr Peter Farrell is the Founder and Executive Chairman of the Board of Resmed. He served as Chief Executive Officer of ResMed from 1990 until 2007. From 1978 to 1989, he was Foundation Director of the Center (now Graduate School ) for Biomedical Engineering at the University of New South Wales where he currently serves as a Visiting Professor. He holds a B.E. in chemical engineering with honors from the University of Sydney , an S.M. in chemical engineering from the Massachusetts Institute of Technology, a Ph.D. in chemical engineering and bioengineering from the University of Washington , Seattle and a D.Sc. from the University of New South Wales .

Dr. Farrell was named 1998 San Diego Entrepreneur of the Year for Health Sciences, Australian Entrepreneur of the Year in 2001 and US National Entrepreneur of the Year for 2005 in Health Sciences. He is Chairman of the Executive Council of the Harvard Medical School Division of Sleep Medicine.  He also serves on the business, engineering and medical school Advisory Boards at UCSD and is Chairman of the Centre for Innovation and Entrepreneurship at the University of New South Wales in Sydney .  In addition to his responsibilities with ResMed, Dr. Farrell is a director of NuVasive, Inc., a NASDAQ-listed company that develops and markets products for the surgical treatment of spine disorders; and he is also non-executive Chairman of QRxPharma a clinical-stage specialty pharmaceutical company listed on the ASX. He is a Fellow or Honorary Fellow of several professional bodies.